mecosar-tyr3-octreotate
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 21, 2015 (NCT04440956)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 64-copper
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04438304 | Phase 2 | Aug 31, 2020 | Clarity Pharmaceuticals Ltd |
| NCT04023331 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2019 | Clarity Pharmaceuticals Ltd |
| NCT04440956 | Early Phase 1 (Phase 1) | May 21, 2015 | Clarity Pharmaceuticals Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clarity Pharmaceuticals Ltd | For profit | 3 | 3 | 2 | 2015 |
1 organizations
Page 1 / 1